Categories

Tripos, L.P. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Tripos) is a healthcare technology company. The company provides scientific consultancy services. Its services include pharmaco kinetic modeling and simulation, predictive disease drug modeling, TQT design and analysis, QT assessment, clinical utility index modeling, non-compartmental analysis, statistical analysis plan, patients writing, manuscripts and medical writing services. In addition, the company develops software for molecular modeling, scientific informatics and trial design. Its software products include D360, Muse, PredictFX, SYBYL-X and Benchware 3D. The company serves pharmaceutical, agrochemical, flavors and fragrances, biotech, chemicals and academic research industries. Its technology partners include ChemAxon, Composite Software, IBM, IDBS, KNIME, Microsoft Corporation, Oracle, Planar Systems, Smartbear, Thomson Reuters and Veristat. The company has operations in Western Europe, Central Europe and South Africa, Australia, Brazil, China, India, Japan, Korea, Malaysia, Singapore and Taiwan. Tripos is headquartered in St. Louis, Missouri, the US.

07-14 2015   Pages: 15

Thomas Jefferson University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Thomas Jefferson) is an educational service provider. The univrsity provides graduate and postdoctoral education and research training in the biomedical sciences. Its institutions include the Jefferson Graduate School of Biomedical Sciences, Jefferson School of Health Professions, Jefferson School of Nursing, Jefferson School of Pharmacy, and Jefferson School of Population Health. Thomas Jefferson’s programs include continuing medical education, continuing nursing education, continuing pharmacy education, Jefferson school of population health forum and Jefferson ultrasoung radiology and education institute. The university provides research activities, such as Jefferson medical college research, departments, centers and institutes, student research opportunities and others. Thomas Jefferson is headquartered in Philadelphia, Pennsylvania, the US.

07-14 2015   Pages: 18

Purdue University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Purdue) is an academic research institution. The university offers undergraduate, post graduate, honors, and research programmes. It also provides off-campus academic programs such as study abroad, distance learning, zip trips and youth programs. Purdue conducts research in the areas of agriculture, business and economy, education, engineering, environment, healthcare, manufacturing, science, technology and veterinary medicine among others. It has four regional campuses in Indiana, such as Indiana University-Purdue University Indianapolis, Indiana University-Purdue University Fort Wayne, Purdue North Central and Purdue Calumet. The university has research collaborations with GE Aviation, Chrysler Group, Africare, XCatholic Relief Services, Moi University and LATeRAL Initiative. Purdue is headquartered in West Lafayette, Indiana, U.S.

07-14 2015   Pages: 17

Ultragenyx Pharmaceutical Inc. (RARE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Ultragenyx) is a biotechnology company. The company develops life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases. Its pipeline includes UX023 (KRN23): anti FGF23 mAb for XLH; UX003: rhGUS for MPS 7; UX004: rhPPCA; UX007: triheptanoin for FAOD; UX007G: triheptanoin for Glut1 DS; and UX001: SA-ER for HIBM. Ultragenyx in collaboration with Kyowa Hakko Kirin Co., Ltd. (KHK) developed and commercialized the product KRN23 for the treatment of XLH including a variety of clinical manifestations, including gross motor impairment, muscle weakness, skeletal deformity, bone pain, short stature, and lower than normal bone density. Ultragenyx is headquartered in Novato, California, the US.

07-14 2015   Pages: 34

The University of Texas M. D. Anderson Cancer Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson provides cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

07-14 2015   Pages: 46

Reaction Biology Corp. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(RBC) is a contract research organization. The company specializes in kinase and epigenetic HTS and profiling services for early stage drug discovery. It develops nanoliter scale assaying methods. RBC’s products include methyltransferase enzymes, reader domain proteins, methyltransferase substrates, and deacetylase proteins. The company also performs NIH-funded research in technology development and early stage drug discovery. It offers services such as antibody and protein microarray production, custom assay development, oxidoreductase assays and compound reformatting. The company serves pharmas, biotechs, academic and non-profit labs. It was formerly known as Morewood Molecular Sciences, Inc. RBC is headquartered in Malvern, Pennsylvania, the US.

07-14 2015   Pages: 21

TransDerm, Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(TransDerm) is a pharmaceutical company. The company develops therapeutics for skin disorders. Its products under clinical development include TD101. TransDerm’s TD101 is a siRNA that targets the keratin 6a (K6a) N171K mutation. The company’s product is used to treat rare dominant disorder pachyonychia congenita. It also develops methods to deliver nucleic acid to inhibit target gene expression in skin such as RNA interface, GeneCreme and dissolvable microneedle arrays. It collaborates with Thermo Fisher Scientific, University of Dundee, Stanford University, CIEMAT, University of Utah, Yale University and PC Project. TransDerm is headquartered in Santa Cruz, California, the US.

07-14 2015   Pages: 22

Targazyme, Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Targazyme), formerly America Stem Cell, Inc., is a biopharmaceutical company. The company develops and commercializes products to improve outcomes for patients receiving cell therapy. Its products include TZ101 and TZ102. Targazyme TZ101 is an enzyme-based treatment for use in cell transplants, which is comprised of recombinant enzyme, a-1,3 fucosyltransferase VI and GDP-fucose. The company’s TZ102 is a cell therapy used to treat neuro-degenerative diseases and cancer. It offers products for the treatment of cancer, heart failure, critical limb ischemia and diabetic retinopathy, and radiation sickness. The company operates in the US and Switzerland. Targazyme is headquartered in Carlsbad, California, the US.

07-14 2015   Pages: 21

SomaGenics Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(SomaGenics) is a biotechnology company. The company develops therapeutics and diagnostics. It concentrates on RNA molecules as therapeutic targets and biomarkers. SomaGenics develops RNAi platform called sshRNA (synthetic short hairpin RNA). The company’s biomarkers help in drug development process, in diagnosing human diseases and monitoring treatment outcomes. Its miR-ID technology is a versatile microRNA detection platform that has been adapted to detect microRNAs from biological fluids. The company has issued patents in all major markets in areas including direct-delivered shRNA therapeutics, nucleic acid detection and directed libraries. SomaGenics is headquartered in Santa Cruz, California, the US.

07-14 2015   Pages: 23

Rex Healthcare – Pharmaceuticals & Healthcare – Deals and Alliances Profile

US$ 250

(Rex) is a healthcare service provider. The hospital provides healthcare services. Its services include bariatric surgery, blood services, diagnostic services, home services, laboratory services, long-term care, mammography services, nursing, occupational health services, pharmacy services, primary care, radiology services, rehabilitation services, senior services, urgent care and women’s services. Rex offers services in the therapeutic areas of radiology, orthopedics, pediatrics, stroke, primary care, urgent care, rehabilitation and wound care, among others. The hospital operates birth center, cancer center, diabetes education center, heartburn center, wound healing center, wellness centers, surgery centers, sleep disorders center and pain management center. It offers its services through its healthcare centers in Apex, Cary, Garner, Holly Springs, Knightdale, and Wakefield. Rex is headquartered in Raleigh, North Carolina, the US.

07-14 2015   Pages: 17
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample